Because AAMs have anti-inflammatory functions, the effects of venestatin on macrophage activation is an interesting topic in studies of the therapeutic potential of venestatin in RAGE-mediated inflammatory diseases, such as Alzheimer’s disease, rheumatoid arthritis, asthma, ulcerative colitis, and diabetes [66–68]. This evidence concerns the gene AGER and ulcerative colitis.